Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$9.78 – $21.41
57% from low
No one on the platform currently holds COEP.
No tracked institution reports a position in COEP as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-12-31 | 1-for-20reverse |
| 2020-08-06 | 200-for-1 |
| 2020-08-06 | 1-for-40000reverse |
No one on the platform has traded COEP yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1M | -25.0% | $-3.40 | $-3.40–$-3.40 | — | 1 |
| 2027 | $766712 | -25.0% | $-3.60 | $-3.60–$-3.60 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-19 | $-0.80 | $-0.12 | +85.0% |
| 2025-03-28 | $-0.80 | $-1.01 | -26.5% |
| 2024-11-13 | $-0.05 | $-0.05 | +0.0% |
| 2024-08-16 | $-0.09 | $-0.08 | +11.1% |
| $45M |
| — |
| MDCXMedicus Pharma Ltd. Common Stock | $0.35 | +6.92% | $8M | — |
| NRXPNRx Pharmaceuticals, Inc. | $3.34 | -0.60% | $58M | — |
Source: Financial Modeling Prep · peers by sector/industry